Predicting Pathological Response after Ipilimumab Plus Nivolumab in Stage III Urothelial Cancer by Liquid-Biopsy Assessment of Plasma and Urine Ctdna Using the RaDaR Assay
CANCER RESEARCH(2022)
Key words
Intratumor Heterogeneity
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined